Furthermore, the current study revealed that HDACIs are able to inhibit AKT/mTOR signaling and its downstream targets, and that the mTOR inhibitor rapamycin reduces the viability of gallbladder carcinoma cells. This evidence concerns the gene AKT1 and gallbladder carcinoma.